Detalhe da pesquisa
1.
DNA Damage Signaling Instructs Polyploid Macrophage Fate in Granulomas.
Cell
; 167(5): 1264-1280.e18, 2016 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28084216
2.
DNA Damage Signaling Instructs Polyploid Macrophage Fate in Granulomas.
Cell
; 174(5): 1325-1326, 2018 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30142346
3.
Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms.
Blood
; 141(23): 2824-2840, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36696631
4.
Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
Blood
; 136(6): 698-714, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32350520
5.
Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives.
Horm Metab Res
; 53(3): 149-160, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33652491
6.
Optimized Xenograft Protocol for Chronic Lymphocytic Leukemia Results in High Engraftment Efficiency for All CLL Subgroups.
Int J Mol Sci
; 20(24)2019 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31842407
7.
Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia.
Haematologica
; 103(1): 136-147, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29122993
8.
Premature terminal differentiation protects from deregulated lymphocyte activation by ITK-Syk.
J Immunol
; 192(3): 1024-33, 2014 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24376268
9.
Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors.
Nature
; 463(7280): 501-6, 2010 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20072125
10.
Insulin-like growth factor-1 receptor (IGF1R) as a novel target in chronic lymphocytic leukemia.
Blood
; 122(9): 1621-33, 2013 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-23863897
11.
Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL.
Blood
; 119(4): 997-1007, 2012 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22130798
12.
Essential role of stromally induced hedgehog signaling in B-cell malignancies.
Nat Med
; 13(8): 944-51, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17632527
13.
Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
Blood
; 115(22): 4497-506, 2010 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-20335218
14.
Azacitidine-induced reconstitution of the bone marrow T cell repertoire is associated with superior survival in AML patients.
Blood Cancer J
; 12(1): 19, 2022 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35091554
15.
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10.
Nat Commun
; 13(1): 925, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35177622
16.
Oncogenic KrasG12D Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice.
Mol Cancer Res
; 19(9): 1596-1608, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34088868
17.
FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale.
Front Endocrinol (Lausanne)
; 12: 712107, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34475850
18.
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Thyroid
; 31(7): 1076-1085, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33509020
19.
Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis.
Cancers (Basel)
; 13(5)2021 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33800365
20.
The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies.
Br J Haematol
; 151(2): 167-78, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20738306